A5087224106- Pregnancy-related medical research
- Assisted Reproductive Technology and Twin Pregnancy
- Ovarian function and disorders
- Reproductive System and Pregnancy
- Renal function and acid-base balance
- Abdominal Surgery and Complications
- Reproductive Biology and Fertility
- Estrogen and related hormone effects
- Trauma, Hemostasis, Coagulopathy, Resuscitation
Narayana Health
2024
Background Dydrogesterone, an oral selective progesterone receptor agonist with high bioavailability, has been used since the 1960s to treat various conditions arising due deficiency of progesterone. Patients are expected have additional compliance and reduced pill burden dydrogesterone 20 mg 30 SR once a day (OD) for requiring 10 twice (BID) or thrice (TID). Methodology A real-world analysis was conducted using HealthPlix electronic medical records (EMR) database understand demography,...
Limited studies have compared pregnancy outcomes with medroxyprogesterone acetate (MPA) vs. gonadotropin-releasing hormone antagonist (GnRH antagonist) in ovarian stimulation protocols. The results show heterogeneity.This study aims to assess the use of MPA instead GnRH for donor-recipient cycles.This retrospective was carried out from June 2016 May 2019. included 250 donors receiving 2 different protocols: group 1 (n = 109) (0.25 mg/day) 5 th or 6 day menses and 141) (10 second menses. In...